Bohl CE[au] - Search Results

Year	Number of Results
2004	2
2005	6
2006	3
2007	1
2008	2
2009	1
2010	1
2011	3
2012	1
2013	1
2018	1
2021	1
2022	1

1

Chemistry and structural biology of androgen receptor.

Gao W, Bohl CE, Dalton JT. Gao W, et al. Among authors: bohl ce. Chem Rev. 2005 Sep;105(9):3352-70. doi: 10.1021/cr020456u. Chem Rev. 2005. PMID: 16159155 Free PMC article. Review. No abstract available.

2

Cancer cachexia therapy: a key weapon in the fight against cancer.

Coss CC, Bohl CE, Dalton JT. Coss CC, et al. Among authors: bohl ce. Curr Opin Clin Nutr Metab Care. 2011 May;14(3):268-73. doi: 10.1097/MCO.0b013e3283455e21. Curr Opin Clin Nutr Metab Care. 2011. PMID: 21415732 Review.

3

Selective androgen receptor modulators in preclinical and clinical development.

Narayanan R, Mohler ML, Bohl CE, Miller DD, Dalton JT. Narayanan R, et al. Among authors: bohl ce. Nucl Recept Signal. 2008;6:e010. doi: 10.1621/nrs.06010. Epub 2008 Nov 26. Nucl Recept Signal. 2008. PMID: 19079612 Free PMC article. Review.

4

Nonsteroidal selective androgen receptor modulators (SARMs): dissociating the anabolic and androgenic activities of the androgen receptor for therapeutic benefit.

Mohler ML, Bohl CE, Jones A, Coss CC, Narayanan R, He Y, Hwang DJ, Dalton JT, Miller DD. Mohler ML, et al. Among authors: bohl ce. J Med Chem. 2009 Jun 25;52(12):3597-617. doi: 10.1021/jm900280m. J Med Chem. 2009. PMID: 19432422 Review. No abstract available.

5

FDG-PET CT in the evaluation of primary and secondary pancreatic malignancies.

Bohl CE, Federico SM, Robinson GW, Bahrami A, Shulkin BL. Bohl CE, et al. Pediatr Blood Cancer. 2018 Oct;65(10):e27115. doi: 10.1002/pbc.27115. Epub 2018 May 11. Pediatr Blood Cancer. 2018. PMID: 29750397

6

PET Imaging and Rate of Pathologic Complete Response in Esophageal Squamous Cell Carcinoma.

Squires MH, Gower N, Benbow JH, Donahue EE, Bohl CE, Prabhu RS, Hill JS, Salo JC. Squires MH, et al. Among authors: bohl ce. Ann Surg Oncol. 2022 Feb;29(2):1327-1333. doi: 10.1245/s10434-021-10644-4. Epub 2021 Oct 9. Ann Surg Oncol. 2022. PMID: 34625880

7

Unexpected binding orientation of bulky-B-ring anti-androgens and implications for future drug targets.

Duke CB, Jones A, Bohl CE, Dalton JT, Miller DD. Duke CB, et al. Among authors: bohl ce. J Med Chem. 2011 Jun 9;54(11):3973-6. doi: 10.1021/jm2000097. Epub 2011 May 16. J Med Chem. 2011. PMID: 21506597

8

Role and pharmacologic significance of cytochrome P-450 2D6 in oxidative metabolism of toremifene and tamoxifen.

Kim J, Coss CC, Barrett CM, Mohler ML, Bohl CE, Li CM, He Y, Veverka KA, Dalton JT. Kim J, et al. Among authors: bohl ce. Int J Cancer. 2013 Mar 15;132(6):1475-85. doi: 10.1002/ijc.27794. Epub 2012 Sep 14. Int J Cancer. 2013. PMID: 22915089 Free article.

9

Structural basis for antagonism and resistance of bicalutamide in prostate cancer.

Bohl CE, Gao W, Miller DD, Bell CE, Dalton JT. Bohl CE, et al. Proc Natl Acad Sci U S A. 2005 Apr 26;102(17):6201-6. doi: 10.1073/pnas.0500381102. Epub 2005 Apr 15. Proc Natl Acad Sci U S A. 2005. PMID: 15833816 Free PMC article.

10

Effect of B-ring substitution pattern on binding mode of propionamide selective androgen receptor modulators.

Bohl CE, Wu Z, Chen J, Mohler ML, Yang J, Hwang DJ, Mustafa S, Miller DD, Bell CE, Dalton JT. Bohl CE, et al. Bioorg Med Chem Lett. 2008 Oct 15;18(20):5567-70. doi: 10.1016/j.bmcl.2008.09.002. Epub 2008 Sep 5. Bioorg Med Chem Lett. 2008. PMID: 18805694 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results